Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Cash from Investing Activities (2016 - 2022)

Historic Cash from Investing Activities for Nephros (NEPH) over the last 9 years, with Q2 2022 value amounting to -$103000.0.

  • Nephros' Cash from Investing Activities changed N/A to -$103000.0 in Q2 2022 from the same period last year, while for Sep 2024 it was -$103000.0, marking a year-over-year change of. This contributed to the annual value of -$50000.0 for FY2024, which is 3333.33% up from last year.
  • Nephros' Cash from Investing Activities amounted to -$103000.0 in Q2 2022.
  • Over the past 5 years, Nephros' Cash from Investing Activities peaked at -$13000.0 during Q3 2020, and registered a low of -$137000.0 during Q1 2019.
  • Its 4-year average for Cash from Investing Activities is -$55142.9, with a median of -$34000.0 in 2022.
  • Per our database at Business Quant, Nephros' Cash from Investing Activities soared by 714.29% in 2020 and then tumbled by 37692.31% in 2021.
  • Nephros' Cash from Investing Activities (Quarter) stood at -$14000.0 in 2019, then grew by 7.14% to -$13000.0 in 2020, then tumbled by 376.92% to -$62000.0 in 2021, then crashed by 66.13% to -$103000.0 in 2022.
  • Its Cash from Investing Activities was -$103000.0 in Q2 2022, compared to -$34000.0 in Q1 2022 and -$62000.0 in Q3 2021.